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E ndothelial disruption and thrombosis are key factors contributing to the de-
velopment of unstable angina and acute myocardial infarction.1-3 However,
angiography, "the gold standard," has been shown to be a relatively insen-
sitive method for detecting these intraluminal changes. Initial reports have sug-
gested that angioscopy could provide valuable information about plaque
morphology in patients with coronary artery disease. These developments, to-
gether with improvements in fiberoptic technology and catheter design, have laid
the groundwork for the advancement of percutaneous coronary angioscopy in the
catheterization laboratory.4l'6 The promise of the angioscope is that direct visual
examination of the surface morphology of a coronary artery will provide more
accurate information than angiography. Theoretically, this enhanced ability to
detect subtle details of plaque morphology will yield improved clinical outcomes
for selected patients undergoing interventional procedures.
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The angioscopic imaging system is made up of components including illumina-
tion fibers, imaging fibers, a video camera and monitor, and a videotape recorder.
The illumination source provides a high-intensity "cold" light to avoid thermal
damage to the vessel being imaged. The imaging bundle consists of at least 2,000
optical fibers for adequate resolution. The video recorder provides an archival
storage medium for reviewing the images.
The angioscope (ImagecathW, Baxter Edwards; Irvine, California, USA) is a cath-
eter within a catheter (Fig. 1). The inner catheter contains 3,000 imaging fibers
and is guided within the coronary artery over a conventional 0.014-inch angio-
plasty guidewire. Although the imaging bundle comprises several thousand
fibers, its diameter is approximately 0.018 inch (similar to that of an angioplasty
guidewire), so the human eye cannot see the completed image without magnifi-
cation. Angioscopy systems employ a high resolution color video camera to dis-
play the magnified mosaic on a color monitor. The image that is carried through
the fiberoptic catheter is magnified and then exposed to the surface of an imaging
sensor within the video camera. Angioscopic systems use a charge coupled de-
vice (CCD) that samples the image for red, green, and blue light and converts that
information into an electronic signal that is recorded onto magnetic tape. Charge
coupled devices are exceptionally sensitive and small in size, both advantages for
an angioscopic imaging sensor. Despite miniaturization, the CCD contains a large
number of sensors, thereby reducing the loss associated with the magnified pro-
jection of the mosaic image onto the monitor.
The outer catheter measures 4.5 Fr in diameter and has a lumen for inflating
and deflating an occlusion balloon at its distal tip. The occlusion balloon is com-
posed of a very compliant material that achieves a variable final diameter, up to a
maximum diameter of 5.0 mm, depending on the volume of liquid introduced. In
the space between the inner catheter and outer catheter, there is room for a solu-
tion to be infused to clear the field of view during inflation of the occlusion bal-
loon. The inner catheter, or imaging bundle, may be advanced or withdrawn
independently of the outer catheter a distance of 6 cm, so that multiple segments
of the vascular lumen can be examined. Both the inner and outer catheters are
guided by the same angioplasty guidewire in a 'monorail" fashion, which facili-
tates rapid exchange.
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Fig. 1 Baxter Imagecath" Angioscope. Top: The occlusion balloon is inflated and the image element is extended over a guidewire.
Bottom: The image element has been retracted into the outer catheter.
Angioscopic Procedure
Vascular access is obtained in the femoral or brachial
artery with an 8-Fr sheath, a conventional angio-
plasty guiding catheter is advanced to the coronary
ostium of interest, and 10,000 units of heparin are
administered. A 0.014-inch angioplasty guidewire is
placed into the distal portion of the coronary artery.
Because the angioscope uses a monorail design that
enables rapid exchange, it may be advanced over a
guidewire into the coronary artery of interest just
proximal to the segment imaged. The flush lumen of
the angioscope is connected to a power injector for
infusion of warmed, lactated Ringer's solution at a
rate of 0.5 to 1.0 cc per second. The occlusion bal-
loon is hand-inflated with a 1-cc syringe filled with a
1:1 mixture of saline and radiographic contrast ma-
terial. Special care is taken not to overinflate the
balloon. The imaging bundle is then advanced over
the guidewire to view the intraluminal surface of the
vessel. Each imaging sequence lasts approximately
30 to 45 seconds, after which the balloon is deflated
and the flush discontinued. These steps can be re-
peated several times, until the region of interest has
been adequately investigated.
When angioscopy is performed in conjunction
with angioplasty, imaging may be performed before
or after treatment, or both. The target lesion is gen-
erally not crossed when imaging is performed before
angioplasty, due to the small size of the vascular lu-
men. Complete imaging of the vessel can be per-
formed after dilation to examine the distal segments
of the vessel not accessible before angioplasty. The
entire sequence, from introducing the angioscope to
obtaining images, can usually be accomplished in




Dramatic differences in plaque morphology have
been observed between patients presenting with
clinical symptoms of stable or unstable angina, when
undisturbed lesions have been imaged with angi-
oscopy before coronary angioplasty."3 Intracoronary
angioscopy of undisturbed lesions (performed be-
fore coronary angioplasty) demonstrated a signifi-
cantly higher occurrence of complex plaque,
including plaque ruptures or dissections and associ-
ated intracoronary thrombi, in patients with unstable
angina than in those with stable angina (Fig. 2).
These results confirmed the intraoperative angios-
copy study by Sherman and coworkers' in which
they documented both a surprisingly high incidence
of intracoronary thrombi in patients with unstable
angina and the insensitivity of angiography in detect-
ing these thrombi. These in vivo findings are con-
sistent with postmortem studies suggesting that the
pathophysiology responsible for the occurrence of
unstable angina is plaque rupture and thrombus for-
mation. 1-
In our own study, we also confirmed that angiog-
raphy was less sensitive than angioscopy in detect-
ing intracoronary thrombi (Table I). To determine
whether the presence of intracoronary thrombus
correlated with procedural complications of angio-
plasty, we performed percutaneous coronary angi-
Fig. 2 A) Angiogram of right coronary lesion (arrow) in a
patient with unstable angina. B) Before percutaneous
angioplasty, angioscopy shows mural thrombus (TH). C) After
percutaneous angioplasty, angioscopy shows the guidewire
(W) in the lumen, and persistent mural thrombus (TH) within
an intimal dissection.
Coronary Angioscopy 21Tavas Heati Institute.journal
TABLE 1. Angiographic versus Angioscopic Sensitivity
and Specificity for Intracoronary Thrombus (n = 122)
Angioscope Angioscope Total
Positive Negative
Angiogram 20 4 24
Positive (TP) (FP)
Angiogram 54 44 98
Negative (FN) (TN)
Total 74 48 122
Angiographic Positive Predictive
Sensitivity = 27% Value = 83%
Angiographic Negative Predictive
Specificity = 92% Value = 45%
FN = false negative; FP = false positive; TN = true negative;
TP = true positive
oscopy in 122 patients before or after angioplasty,
or both.17 Patients were treated with routine angio-
plasty techniques; no thrombolytic agent was admin-
istered. Stable angina was present in 27 patients, and
unstable angina was present in 95 patients. Angios-
copy demonstrated that patients with unstable an-
gina had a much higher incidence of intracoronary
thrombus (70/95 patients; 74%) than did patients
with stable angina (4/27; 15%) (p <0.001).
In-hospital adverse outcomes, defined either as
the occurrence of major sequelae (death, myocardial
infarction, or emergency bypass) or as the recur-
rence of ischemic events (angina, abrupt occlusion,
or repeat angioplasty), were associated with the
presence of angioscopically identified intracoronary
thrombus. A major sequela occurred in 10 of 95
(11%) patients with unstable angina, compared with
none of the 27 stable angina patients (p=0.07); and
recurrent ischemic events occurred in 22 of 95 (23%)
unstable angina patients, compared with 2 of 27 (7%)
stable angina patients (p = 0.05). The presence of
intracoronary thrombus appeared to be associated
with adverse outcomes after coronary angioplasty.
Abrupt Occlusion after Angioplasty
Abrupt occlusion of a coronary artery is the major
cause of morbidity and mortality associated with per-
cutaneous transluminal coronary angioplasty. 18-23
Therapy intended to reopen occluded vessels is ei-
ther empirical or guided by angiographic imaging of
lesion morphology that has inherent limitations in
specifically identifying the cause of the occlusion. In
order to directly visualize the intravascular morphol-
ogy of abruptly occluded vessels, we performed per-
cutaneous coronary angioscopy in 17 patients with
abrupt occlusion after coronary angioplasty and
compared the results of angioscopy with those of
angiography. 2
Angioscopy demonstrated that the most common
cause of the abrupt occlusion was dissection, with
only a minority of cases due to coronary thrombosis.
Compared with angioscopy, angiography was sig-
nificantly less accurate in identifying a specific cause
of the occlusion, correctly identifying only 4 of 14
(29%) occlusive dissections and 1 of 3 (33%) intra-
luminal thrombi. Dissection, characterized by bulky
tissue fragments obstructing the lumen of the vessel,
was the primary cause of the occlusion in 14 of 17
(82%) vessels. In 3 of 17 (18%) vessels, occlusive
intraluminal thrombi were seen. All 3 patients with
occlusive intraluminal thrombi had unstable angina,
including 2 patients with postmyocardial infarction
angina and 1 patient with a crescendo pattern of
angina.
We also used the angioscopic images to guide sal-
vage therapy. The 3 patients with occlusive thrombi
were treated with a selective infusion of 250,000
units of intracoronary urokinase (Abbokinase, Ab-
bott Laboratories; Abbott Park, Illinois, USA) over 30
minutes (Fig. 3). Urokinase was used alone in 1 pa-
tient and as an adjunct to repeat balloon dilation in
2 patients. Two patients had their angioplasty pro-
cedures successfully salvaged without infarction. The
3rd patient's vessel was successfully recanalized;
however, patency could not be sustained, and he
was sent for emergency bypass surgery with a per-
fusion balloon in place to maintain flow.
Among the procedures performed in the 14 pa-
tients with occlusive dissections, long balloon infla-
tions were unable to reopen 2 occluded vessels, and
the patients were sent for emergency coronary by-
pass surgery. In the remaining 12 patients with oc-
clusive dissections, 8 patients were successfully
treated with repeat balloon dilation, 3 were success-
fully treated with repeat balloon dilation and direc-
tional coronary atherectomy, and 1 was treated with
stent implantation.
Fig. 3 Left: Intraluminal red thrombus is present at 11 o'clock.
Right: After urokinase infusion, the red thrombus has
resolved.
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Saphenous Vein Grafts
The results of percutaneous angioscopy and angi-
ography for detecting critical elements of surface
lesion morphology were compared in 21 patients un-
dergoing balloon angioplasty of saphenous vein
coronary bypass grafts.25 Angioscopy and angiog-
raphy were performed before and after angioplasty
of "culprit lesions" in bypass grafts. All but 1 of the
patients had unstable angina. The mean age of the
saphenous vein coronary bypass grafts was 10.1 +
2.4 years (range, 5 to 15 years). There was no corre-
lation between age of the bypass graft and the pres-
ence of friable plaque. On the basis of our results
(Table II), we concluded that angioscopy is superior
to angiography for detecting complex lesion mor-
phology in bypass grafts.
Future Applications
of Angioscopy
The correlation of atherosclerotic lesion morphology
with clinical outcomes has been the cornerstone of
our understanding of atherosclerosis and has guided
our treatment of patients with this disease. The land-
mark study by DeWood and colleagues26 made clear
the role of intracoronary thrombosis in the pathogen-
esis of myocardial infarction and dramatically altered
the standard of therapy from supportive care to
interventional therapy with thrombolytic agents.
Angiographic studies of coronary morphology in pa-
tients with stable and unstable angina have enabled
us to identify patients with high-risk lesions.27-29
However, these studies have been limited by the
documented insensitivity of angiography in assess-
ing residual stenosis after angioplasty and in detect-
ing subtle changes in coronary artery surface
morphology, such as plaque fractures, dissections,
and intracoronary thrombi.30Y4
When compared with angiography, angioscopy
offers a superior sensitivity and specificity for identi-
fying subtle changes in atherosclerotic plaque mor-
phology. Like angiography, this is a percutaneous
technique that can be used to more closely examine
suspect regions or lesions. Angioscopy enables the
in vivo examination of the abnormality present on
TABLE II. Comparison of Angioscopy and Angiography
in Saphenous Vein Grafts (n = 21)
Friable
Thrombus Dissection Plaque
Angioscopy 15 (71%) 14 (66%) 11 (52%)
Angiography 4 (19%) 2 (10%) 5 (24%)
p-value <0.001 <0.01 <0.05
the surface of the coronary artery. Our early studies
suggest that angioscopy has the potential to improve
understanding of coronary artery lesion morphology
in patients with acute ischemic syndromes, resteno-
sis after angioplasty, and saphenous vein graft dis-
ease.
Percutaneous coronary angioscopy may play a
role in guiding interventional coronary therapy.
Angioscopy, when compared with angiography, is
better able to detect small amounts of intracoronary
thrombus that may have a negative impact on the
outcome of angioplasty in patients with acute ische-
mic syndromes. Current studies are under way to
determine if the angioscopic detection of intra-
coronary thrombus in patients undergoing balloon
angioplasty can identify those at higher risk of com-
plications from the procedure. Perhaps the admin-
istration of adjunctive thrombolytic therapy, either
before or after balloon dilation, will eventually be
guided by angioscopic findings.
Summary
Coronary angioscopy will not replace angiography
as the gold standard for imaging atherosclerotic
coronary arteries. However, there may well be a
clinical niche for a technology that gives accurate
information regarding a specific lesion, if that infor-
mation can be used to improve the acute or chronic
outcome of an interventional procedure. Our expe-
rience demonstrates that angioscopy indeed pro-
vides this information. Using angioscopy, we now
have access to information regarding arterial wall
disease that heretofore has been available only at
necropsy. In addition, whereas angiography has pro-
vided only a 2-dimensional, gray-scale image of the
coronary vessels, angioscopy offers a full-color, 3-
dimensional perspective of the intracoronary surface
morphology. These important lesion-specific details,
not reliably available from angiography alone, may
ultimately be used to improve patient outcome and
to assess risk.
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